← FDA DRUG APPROVALS

FDA ANDA · ANDA040265

METHOTREXATE PRESERVATIVE FREE

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA040265
TYPE
ANDA
ORIGINAL APPROVAL
1999-02-26
LATEST ACTION
2017-03-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METHOTREXATE PRESERVATIVE FREEDiscontinued
METHOTREXATE SODIUM EQ 25MG BASE/ML · INJECTABLE · INJECTION

Approval history

2017-03-03Labeling · Supplement 14 · standardAP
2002-12-02Manufacturing (CMC) · Supplement 6AP
2001-10-16Labeling · Supplement 5AP
2001-10-16Manufacturing (CMC) · Supplement 3AP
2001-10-16Manufacturing (CMC) · Supplement 4AP
2001-10-16Manufacturing (CMC) · Supplement 2AP
2000-02-17Manufacturing (CMC) · Supplement 1AP
1999-02-26OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →